My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

ImmunityBio, Inc. - Common Stock (NQ:IBRX)

7.720 -0.470 (-5.74%)

Streaming Delayed Price Updated: 11:06 AM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ImmunityBio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy ↗

May 03, 2024

Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer.

Via Benzinga

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗

May 03, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 02, 2024

Via Benzinga

Check Out What Whales Are Doing With IBRX ↗

April 30, 2024

Via Benzinga

ImmunityBio: Q4 Earnings Insights ↗

March 19, 2024

Via Benzinga

Stocks Quietly Climb Ahead Of Central Bank Storm ↗

April 29, 2024

The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are all sporting comfortable leads this afternoon.

Via Talk Markets

Topics Economy Stocks

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket ↗

April 29, 2024

Via Benzinga

What's Going On With ImmunityBio Stock? ↗

April 26, 2024

ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 26, 2024

Via Benzinga

Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2024

Via Benzinga

FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies ↗

April 23, 2024

FDA approves ImmunityBio's Anktiva plus Bacillus Calmette-Guérin for BCG-unresponsive non-muscle invasive bladder cancer. Anktiva shows promising complete response rates and duration exceeding 24...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 23, 2024

Via Benzinga

Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

April 23, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 23, 2024

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 20, 2024

Via Benzinga

Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday ↗

March 20, 2024

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.

Via Benzinga

Topics Stocks

IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q4 2023 ↗

March 19, 2024

IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 26, 2024

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 26, 2024

Via Benzinga

Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2024

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 26, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

February 26, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

Via Benzinga

Topics Stocks

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 23, 2024

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 23, 2024

Via Benzinga

Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 23, 2024

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.

Via Benzinga

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 ↗

January 02, 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.

Via InvestorPlace

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.